TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 44 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quantum Private Wealth, LLC | 359,367 | $286,632 | 0.16% |
| Sands Capital Ventures, LLC | 724,873 | $579,898 | 0.14% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,500,000 | $1,196,400 | 0.12% |
| Nantahala Capital Management | 1,722,400 | $1,350,706 | 0.10% |
| Artal Group S.A. | 1,440,882 | $1,149 | 0.07% |
| CARLSON CAPITAL L P | 504,000 | $401,990 | 0.04% |
| Redwood Wealth Management Group, LLC | 37,750 | $30,109 | 0.03% |
| Alphabet Inc. | 640,882 | $512,706 | 0.03% |
| XTX Topco Ltd | 85,167 | $67,929 | 0.01% |
| CORNERCAP INVESTMENT COUNSEL INC | 55,359 | $44,154 | 0.01% |
| Laurion Capital Management LP | 1,292,600 | $1,030,978 | 0.01% |
| Camelot Portfolios, LLC | 11,000 | $8,774 | 0.01% |
| Virtu Financial LLC | 45,459 | $36 | 0.00% |
| Sargent Investment Group, LLC | 19,569 | $15,068 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 156,300 | $124,665 | 0.00% |
| GSA CAPITAL PARTNERS LLP | 27,338 | $22 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 405,301 | $321 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,255 | $6 | 0.00% |
| JPMORGAN CHASE & CO | 1,782 | $1,000 | 0.00% |
| Renaissance Technologies | 249,600 | $199 | 0.00% |
External links
This page lists TAYSHA GENE THERAPIES INC's shareholders in Q1 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.